Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound

被引:46
作者
Saracco, Ariel [1 ]
Szabo, Botond K. [2 ]
Aspelin, Peter [1 ]
Leifland, Karin [3 ]
Wilczek, Brigitte [3 ]
Celebioglu, Fuat [4 ]
Axelsson, Rimma [1 ]
机构
[1] Karolinska Inst, Div Med Imaging & Technol, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden
[2] Univ Szeged, Dept Radiol, Szeged, Hungary
[3] ST Goran Hosp, Div Radiol, Dept Breast Imaging, Stockholm, Sweden
[4] Brostctr Sodersjukhuset, Div Breast Surg, Stockholm, Sweden
关键词
Contrast-enhanced ultrasound; breast tumors; kinetic parameters; COLOR DOPPLER US; EUROPEAN COUNTRIES; CANCER MORTALITY; TREND ANALYSIS; DIAGNOSIS; ANGIOGENESIS; MAMMOGRAPHY; AGENT;
D O I
10.1258/ar.2012.110562
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Contrast-enhanced ultrasound (CEUS) has gained interest because of its ability to gather vascular information in diverse organs. There is still a subject of debate concerning its value in breast lesions, especially as a differential diagnostic tool. Purpose: To investigate whether kinetic parameters of CEUS can differentiate between malignant and benign breast lesions. Material and Methods: We evaluated 75 malignant and 21 benign lesions in the breast or axilla. Contrast harmonic imaging (CHI) US was performed after the injection of a bolus dose of 2.4 mL of Sono Vue (R) (Bracco, Milano, Italy). The following parameters were calculated for kinetic analysis: initial slope, time to peak enhancement, wash-out ratios W-21 and W-50 (relative decrease in signal intensity from the peak enhancement to 21 s and 50 s, respectively). Results: A significant difference was found between the benign and malignant lesions in time-to-peak (P value <0.05) and wash-out ratios W-21 (P value <0.001) and W-50 (P value <0.001). The mean time-to-peak was 9.3 s for malignant and 14.6 s for benign lesions. The mean signal drop from peak to signal intensity measured at 50 s was 85% for malignant and 66% for benign lesions. There was no difference in absolute values of peak signal intensity and initial slope. The most significant difference between standardized benign and malignant wash-out curves was found at 21 s but statistical significance was reached in the range of 14-50s. Conclusion: Real-time CEUS can evolve into a new non-invasive option for differentiate malignant from benign breast lesions.
引用
收藏
页码:382 / 388
页数:7
相关论文
共 33 条
  • [1] Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database
    Autier, Philippe
    Boniol, Mathieu
    Gavin, Anna
    Vatten, Lars J.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [2] Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database
    Autier, Philippe
    Boniol, Mathieu
    LaVecchia, Carlo
    Vatten, Lars
    Gavin, Anna
    Hery, Clarisse
    Heanue, Mary
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2010, 341 : 335
  • [3] New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literature
    Balleyguier, Corinne
    Opolon, Paule
    Mathieu, Marie Christine
    Athanasiou, Alexandra
    Garbay, Jean Remi
    Delaloge, Suzette
    Drornain, Clarisse
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2009, 69 (01) : 14 - 23
  • [4] Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions
    Beaton, C.
    Cochlin, D.
    Kumar, N.
    [J]. EJSO, 2010, 36 (01): : 43 - 46
  • [5] Boné B, 2003, ACTA RADIOL, V44, P28
  • [6] Influence of preoperative MRI on the surgical management of patients with operable breast cancer
    Braun, Michael
    Poelcher, Martin
    Schrading, Simone
    Zivanovic, Oliver
    Kowalski, Theresa
    Flucke, Uta
    Leutner, Claudia
    Park-Simon, Tong-Wong
    Rudlowski, Christian
    Kuhn, Walther
    Kuhl, Christiane K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 111 (01) : 179 - 187
  • [7] Caruso Giuseppe, 2002, Radiol Med, V104, P443
  • [8] Cassano E, 2006, Cancer Imaging, V6, P4, DOI 10.1102/1470-7330.2006.0001
  • [9] BREAST DISEASES - COLOR DOPPLER US IN DIFFERENTIAL-DIAGNOSIS
    COSGROVE, DO
    KEDAR, RP
    BAMBER, JC
    ALMURRANI, B
    DAVEY, JBN
    FISHER, C
    MCKINNA, JA
    SVENSSON, WE
    TOHNO, E
    VAGIOS, E
    ALSANJARI, NA
    [J]. RADIOLOGY, 1993, 189 (01) : 99 - 104
  • [10] COLOR DOPPLER SIGNALS FROM BREAST-TUMORS - WORK IN PROGRESS
    COSGROVE, DO
    BAMBER, JC
    DAVEY, JB
    MCKINNA, JA
    SINNETT, HD
    [J]. RADIOLOGY, 1990, 176 (01) : 175 - 180